IP Verse

Respiratory Virus Vaccines - EP3718565

The patent EP3718565 was granted to Moderna on Apr 27, 2022. The application was originally filed on Oct 21, 2016 under application number EP20164728A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3718565

MODERNA
Application Number
EP20164728A
Filing Date
Oct 21, 2016
Status
Granted And Under Opposition
Mar 25, 2022
Grant Date
Apr 27, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PFIZERJan 27, 2023EDERADMISSIBLE
WITHERS & ROGERSJan 26, 2023GRAF VON STOSCH PATENTANWALTSGESELLSCHAFTADMISSIBLE
SANOFIDec 9, 2022CARPMAELS & RANSFORDADMISSIBLE
BIONTECHSep 23, 2022HOPFNERADMISSIBLE

Patent Citations (51) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONUS2013266640
OPPOSITIONUS2014105966
OPPOSITIONWO2005027963
OPPOSITIONWO2005118813
OPPOSITIONWO2008083949
OPPOSITIONWO2009127230
OPPOSITIONWO2010088927
OPPOSITIONWO2010129709
OPPOSITIONWO2011005799
OPPOSITIONWO2011150264
OPPOSITIONWO2012006369
OPPOSITIONWO2012006372
OPPOSITIONWO2012006377
OPPOSITIONWO2012030901
OPPOSITIONWO2012031046
OPPOSITIONWO2012045075
OPPOSITIONWO2012099805
OPPOSITIONWO2012116810
OPPOSITIONWO2012116811
OPPOSITIONWO2012135805
OPPOSITIONWO2013052523
OPPOSITIONWO2013090648
OPPOSITIONWO2013151664
OPPOSITIONWO2013151736
OPPOSITIONWO2013182683
OPPOSITIONWO2014081507
OPPOSITIONWO2014089486
OPPOSITIONWO2014093574
OPPOSITIONWO2014152211
OPPOSITIONWO2014152540
OPPOSITIONWO2014159813
OPPOSITIONWO2015006747
OPPOSITIONWO2015024667
OPPOSITIONWO2015048744
OPPOSITIONWO2015081155
OPPOSITIONWO2015095340
OPPOSITIONWO2015095346
OPPOSITIONWO2015143335
OPPOSITIONWO2015164674
OPPOSITIONWO2016138160
OPPOSITIONWO2017070626
OPPOSITIONWO2021213945
OPPOSITIONWO2022137133
SEARCHWO2005027963
SEARCHWO2012006369
SEARCHWO2012031043
SEARCHWO2013090648
SEARCHWO2013185069
SEARCHWO2014089486
SEARCHWO2014144196
SEARCHWO2015095340

Non-Patent Literature (NPL) Citations (76) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Andrew Geall; E.C. Settembre; J. B. Ulmer, "Using self-amplifying mRNAvaccines to facilitate a rapidresponse to pandemic influenza", EUROPEAN PHARMACEUTICAL REVIEW, RUSSELL, LONDON, GB, GB , (20131231), vol. 19, no. 3, ISSN 1360-8606, pages 20 - 23, XP009552460-
OPPOSITION- Anonymous, "AN AUDIENCE WITH Moncef Slaoui", Nature News & Views, Nature Reviews Drug Discovery, (20150701), vol. 14, pages 452 - 453, XP093136923-
OPPOSITION- Anonymous, "Comirnaty", EMA (European Medicine Agency), (20230103), EMA (European Medicine Agency), URL: https://web.archive.org/web/20230103092258/https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf, (20240125), XP093123663-
OPPOSITION- Anonymous, "Coronavirus", Wikipedia, the free encyclopedia, (20230902), Wikipedia, the free encyclopedia, URL: https://en.wikipedia.org/w/index.php?title=Coronavirus&oldid=1173402921, (20240305), XP093137805-
OPPOSITION- Anonymous , "Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099}; Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099}", Uniprot KB, (20030423), Database accession no. P59594, URL: Uniprot, XP093026128-
OPPOSITION- Anonymous, " spike glycoprotein [Middle East respiratory syndrome-related coronavirus] - revision history", NCBI, (20140724), NCBI, (20240125), XP093123652-
OPPOSITION- Anonymous , "spike protein [Middle East respiratory syndrome-related coronavirus]", PROTEIN, URL: NCBI, XP093140517-
OPPOSITION- Anonymous, "Spikevax ", EMA (European Medicine Agency), (20230209), EMA (European Medicine Agency), URL: https://web.archive.org/web/20230209152036/https://www.ema.europa.eu/en/documents/product-information/spikevax-previously-covid-19-vaccine-moderna-epar-product-information_en.pdf, (20240125), XP093123644-
OPPOSITION- Anonymous , "S protein [Human betacoronavirus 2c EMC/2012]", PROTEIN, (20121204), Database accession no. AFS88936, URL: GENBANK, XP093143613-
OPPOSITION- Dormitzer Philip R., " Synthetic Vaccinology at Novartis", Novartis (THE NATIONAL ACADEMY OF SCIENCES FORUM ON SYNTHETIC BIOLOGY), (20131021), XP093136926-
OPPOSITION- F. W. Johanning, R. M. Conry, A. F. LoBuglio, M. Wright, L. A. Sumerel, M. J. Pike, D. T. Curiel, "A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo", Nucleic Acids Research, GB , (19950511), vol. 23., no. 9, doi:10.1093/nar/23.9.1495, ISSN 0305-1048, pages 1495 - 1501., XP002021791-
OPPOSITION- KUHN et al., "mRNA as a Versatile Tool for Exogenous Protein Expression", Current Gene Therapy, (20121012), vol. 12, pages 347 - 361, XP008159357-
OPPOSITION- Maclachlan Ian, "Lipid Nanoparticle-Mediated Delivery of Messenger RNA ", Tekmira, (20131024), pages 1 - 32, XP093143624-
OPPOSITION- REICHMUTH et al., "mRNA vaccine delivery using lipid nanoparticles", Therapeutic Delivery, (20160414), vol. 7, no. 5, pages 319 - 334, XP002778263-
OPPOSITION- Shim Byoung-Shik et al, "Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/ polyethylenimine nanoparticles elicits antigen- specific humoral and cellular immune responses", BMC Immunology, (20100101), vol. 11, no. 65, pages 1 - 9, XP093026057-
OPPOSITION- Weissman Drew, "mRNA transcript therapy", Exp. Rev. Vaccines, (20150101), vol. 14, no. 2, pages 265 - 281, XP093023863-
OPPOSITION- Engler Renata ] M, Michael R. Nelson, Mary M. Klote,Mark Jvanraden, Chiung-Yu Huang, Nancy J Cox, Alexander Klimov,Wendy A. Keitel, Kristin L. Nichol, Warner W. Carr, John J Treanor, "Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) ", JAMA Internal Medicine, (20080822), vol. 168, no. 22, doi:10.1001/archinternmed.2008.513, pages 2405 - 2414, XP093143650
OPPOSITION- M. JAYARAMAN et al., "Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo", Angewandte Chemie Int. Ed., (20120000), vol. 51, doi:10.1002/anie.201203263, pages 8529 - 8533, XP055063645
OPPOSITION- F Martinon , S Krishnan, G Lenzen, R Magné, E Gomard, J G Guillet, J P Lévy, P Meulien, "Induction of virus-specific cytotoxic T lymphocytesin vivo by liposome-entrappedmRNA", European Journal of Immunology, Hoboken, USA, (19930601), vol. 23, no. 7, doi:10.1002/eji.1830230749, ISSN 0014-2980, pages 1719 - 1722, XP002937540
OPPOSITION- Walls Alexandra, Tortorici M. Alejandra, Bosch Berend‐jan, Frenz Brandon, Rottier Peter J. M., Dimaio Frank, Rey Felix A., Veesler David, "Crucial steps in the structure determination of a coronavirus spike glycoprotein using cryo‐electron microscopy", Protein Science, US , (20170101), vol. 26, no. 1, doi:10.1002/pro.3048, ISSN 0961-8368, pages 113 - 121, XP093144050
OPPOSITION- Tews Birke Andrea, Meyers Gregor, "Self-Replicating RNA : Methods and Protocols", Tews Birke Andrea, Meyers Gregor, Kramps T, Elbers K., RNA Vaccines : Methods and Protocols, New York, NY, Springer New York, (20170101), vol. 1499, pages 15 - 35, doi:10.1007/978-1-4939-6481-9_2, ISSN 1064-3745, ISBN 978-1-4939-6481-9, XP093066456
OPPOSITION- Pascolo Steve, "Vaccination with messenger RNA (mRNA)", Toll-like receptors (TLRs) and innate immunity, DE , (20080101), vol. 183, doi:10.1007/978-3-540-72167-3_11, ISBN 978-3-540-72166-6, pages 221 - 235, XP001538300
OPPOSITION- Luis A. Brito, Sushma Kommareddy, Domenico Maione, Yasushi Uematsu, Cinzia Giovani, Francesco Berlanda Scorza, Gillis Otten, Dong Yu, Christian Mandl, Peter Mason, Philip Dormitzer, Jeffrey Ulmer, Andrew Geall, Leaf Huang, Dexi Liu, Ernst Wagner, "Self-Amplifying mRNA Vaccines", Advances in Genetics, US , Academic Press , (20150101), vol. 89, pages 179 - 233, doi:10.1016/bs.adgen.2014.10.005, ISSN 0065-2660, XP055301432
OPPOSITION- Y. HE et al., "Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine", Biochemical and Biophysical Research Communications, (20040000), vol. 324, doi:10.1016/j.bbrc.2004.09.106, pages 773 - 781, XP027154373
OPPOSITION- Norbert Pardi et al, "Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20151101), vol. 217, doi:10.1016/j.jconrel.2015.08.007, ISSN 0168-3659, pages 345 - 351, XP055231069
OPPOSITION- N. PARDI et al., "Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes", Journal of Controlled Release, (20150000), vol. 217, doi:10.1016/j.jconrel.2015.08.007, pages 345 - 351, XP055722698
OPPOSITION- Geall Andrew J.; Mandl Christian W.; Ulmer Jeffrey B., "RNA: The new revolution in nucleic acid vaccines", Seminars in immunology, W.B. SAUNDERS COMPANY, PA., US, US , (19000101), vol. 25, no. 2, doi:10.1016/j.smim.2013.05.001, ISSN 1044-5323, pages 152 - 159, XP028694558
OPPOSITION- Jeffrey B. Ulmer et al, "RNA-based vaccines", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20120418), vol. 30, no. 30, doi:10.1016/j.vaccine.2012.04.060, ISSN 0264-410X, pages 4414 - 4418, XP028520925
OPPOSITION- K. MODJARRAD, "MERS-Co V vaccine candidates in development: The current landscape", Vaccine, (20160400), vol. 34, doi:10.1016/j.vaccine.2016.03.104, pages 2982 - 2987, XP029560777
OPPOSITION- Du, L. et al, "Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines", Virology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20060915), vol. 353, no. 1, doi:10.1016/j.virol.2006.03.049, ISSN 0042-6822, pages 6 - 16, XP005614450
OPPOSITION- L. DU et al., "Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines", Virology, (20060000), vol. 353, doi:10.1016/j.virol.2006.03.049, pages 6 - 16, XP024896372
OPPOSITION- Rossi Shannan L. et al, "IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice", Virology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20130122), vol. 437, no. 2, doi:10.1016/j.virol.2012.11.013, ISSN 0042-6822, pages 81 - 88, XP028978699
OPPOSITION- Escriou Nicolas; Callendret Benoît; Lorin Valérie; Combredet Chantal; Marianneau Philippe; Février Michèle; Tangy Frédéric , "Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein", Virology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (19000101), vol. 452, doi:10.1016/j.virol.2014.01.002, ISSN 0042-6822, pages 32 - 41, XP028627222
OPPOSITION- Liping Huang; Yuehua Lu; Yanwu Wei; Longjun Guo; Hongli Wu; Feiyan Zhang; Yujie Fu; Changming Liu;, "Construction and biological characterisation of recombinant porcine circovirus type 2 expressing the V5 epitope tag", Virus research, NL , (20110519), vol. 161, no. 2, doi:10.1016/j.virusres.2011.05.015, ISSN 0168-1702, pages 115 - 123, XP028297796
OPPOSITION- Thery, C , Amigorena, S., "The cell biology of antigen presentation in dendritic cells", Current Opinion in Immunology, GB , (20010201), vol. 13, no. 1, doi:10.1016/S0952-7915(00)00180-1, ISSN 0952-7915, pages 45 - 51, XP004257760
OPPOSITION- A. HEKELE et al., "Rapidly produced SAM@ vaccine against H7N9 influenza is immunogenic in mice", Emerging Microbes and Infections, (20130000), vol. 2, pages 1 - 7, XP055397456
OPPOSITION- KARIKÓ KATALIN ET AL, "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.", Molecular Therapy, Nature Publishing Group, GB, GB , (20081101), vol. 16, no. 11, doi:10.1038/mt.2008.200, ISSN 1525-0024, pages 1833 - 1840, XP002598556
OPPOSITION- G. BASHA et al., "Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells", Molecular Therapy, (20110000), vol. 19, no. 12, doi:10.1038/mt.2011.190, pages 2186 - 2200, XP055024764
OPPOSITION- Genc Basha et al, "Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells", Molecular Therapy, No longer published by Elsevier, (20111201), vol. 19, no. 12, doi:10.1038/mt.2011.190, ISSN 15250016, pages 2186 - 2200, XP055024764
OPPOSITION- Charlotte Pollard, Joanna Rejman , Winni De Haes , Bernard Verrier , Ellen Van Gulck , Thomas Naessens , Stefaan De Smedt , Pieter Bogaert , Johan Grooten , Guido Vanham , Stefaan De Koker, "Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines", Molecular Therapy, US , (20130101), vol. 21, no. 1, doi:10.1038/mt.2012.202, ISSN 1525-0016, pages 251 - 259, XP055378387
OPPOSITION- M. MAIER et al., "Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics", Molecular Therapy, (20130000), vol. 21, no. 8, doi:10.1038/mt.2013.124, pages 1570 - 1578, XP055237159
OPPOSITION- Andreas Thess, Stefanie Grund, Barbara L Mui, Michael J Hope, Patrick Baumhof, Mariola Fotin-Mleczek, Thomas Schlake, "Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals", Molecular Therapy, US , (20150901), vol. 23, no. 9, doi:10.1038/mt.2015.103, ISSN 1525-0016, pages 1456 - 1464, XP055316910
OPPOSITION- Z. YANG et al., "A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice", Letters to Nature, (20040000), vol. 428, doi:10.1038/nature02463, pages 561 - 564, XP037065776
OPPOSITION- S. SEMPLE et al., "Rational design of cationic lipids for siRNA delivery", Nature Biotechnology, (20100000), vol. 28, no. 2, pages 172 - 178, XP055539273
OPPOSITION- Sean C Semple et al, "Rational design of cationic lipids for siRNA delivery", Nature Biotechnology, Nature Publishing Group US, New York, New York, (20100201), vol. 28, no. 2, doi:10.1038/NBT.1602, ISSN 1087-0156, pages 172 - 176, XP002633693
OPPOSITION- Leuschner Florian, Dutta Partha, Gorbatov Rostic, Novobrantseva Tatiana I, Donahoe Jessica S, Courties Gabriel, Lee Kang Mi, Kim James I, Markmann James F, Marinelli Brett, Panizzi Peter, Lee Won Woo, Iwamoto Yoshiko, Milstein Stuart, Epstein-Barash Hila, Cantley William, Wong Jamie, Cortez-Retamozo Virna, Newton Andita, Love Kevin, Libby Peter, Pittet Mikael J, Swirski Filip K, Koteliansky Victor, Langer Robert, Weissleder Ralph, Anderson Daniel G, Nahrendorf Matthias, "Therapeutic siRNA silencing in inflammatory monocytes in mice", Nature Biotechnology, New York, (20111101), vol. 29, no. 11, doi:10.1038/nbt.1989, ISSN 1087-0156, pages 1 - 18, XP093143685
OPPOSITION- Benjamin Petsch et al, "Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection", Nature Biotechnology, Gale Group Inc., (20120101), vol. 30, no. 12, doi:10.1038/nbt.2436, ISSN 10870156, pages 1210 - 1216, XP055051005
OPPOSITION- Ugur Sahin, Katalin Karikó, Özlem Türeci, "mRNA-based therapeutics — developing a new class of drugs", Nature Reviews Drug Discovery, Nature Pub. Group, vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 14741776, pages 759 - 780, XP055159205
OPPOSITION- DU et al., "The spike protein of SARS-CoV - a target for vaccine and therapeutic development", Nature Reviews Microbiology, (20090209), vol. 7, doi:10.1038/nrmicro2090, pages 226 - 236, XP037065603
OPPOSITION- L. DU et al., "The spike protein of SARS-CoV - a target for vaccine and therapeutic development", Nature Reviews, (20090000), vol. 7, doi:10.1038/nrmicro2090, pages 226 - 236, XP037065603
OPPOSITION- Love Kevin T., Mahon Kerry P., Levins Christopher G., Whitehead Kathryn A., Querbes William, Dorkin J. Robert, Qin June, Cantley William, Qin Liu Liang, Racie Timothy, Frank-Kamenetsky Maria, Yip Ka Ning, Alvarez Rene, Sah Dinah W. Y., De Fougerolles Antonin, Fitzgerald Kevin, Koteliansky Victor, Akinc Akin, Langer Robert, Anderson Daniel G., "Lipid-like materials for low-dose, in vivo gene silencing", Proceedings of the National Academy of Sciences, (20100202), vol. 107, no. 5, doi:10.1073/pnas.0910603106, ISSN 0027-8424, pages 1864 - 1869, XP093143656
OPPOSITION- A. GEALL et al., "Nonviral delivery of self-amplifying RNA vaccines", PNA S, (20120000), doi:10.1073/PNAS.1209367109, pages 14604 - 14609, XP002683929
OPPOSITION- Andrew J. Geall, Ayush Verma, Gillis R. Otten, Christine A. Shaw, Armin Hekele, Kaustuv Banerjee, Yen Cu, Clayton W. Beard, Luis A. Brito, Thomas Krucker, Derek T. O�Hagan, Manmohan Singh, Peter W. Mason, Nicholas M. Valiante, Philip R. Dormitzer, Susan W. Barnett, Rino Rappuoli, Jeffrey B. Ulmer, Christian W. Mandl, "Nonviral delivery of self-amplifying RNA vaccines.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20120904), vol. 109, no. 36, doi:10.1073/PNAS.1209367109, ISSN 0027-8424, pages 14604 - 14609, XP002683929
OPPOSITION- Andrew J. Geall et al, "Nonviral delivery of self-amplifying RNA vaccines.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20120904), vol. 109, no. 36, doi:10.1073/PNAS.1209367109, ISSN 0027-8424, pages 14604 - 14609, XP002683929
OPPOSITION- Walls Alexandra C., Tortorici M. Alejandra, Snijder Joost, Xiong Xiaoli, Bosch Berend-Jan, Rey Felix A., Veesler David, "Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion", Proceedings of the National Academy of Sciences, (20171017), vol. 114, no. 42, doi:10.1073/pnas.1708727114, ISSN 0027-8424, pages 11157 - 11162, XP055825682
OPPOSITION- Katalin Karikó, Hiromi Muramatsu, János Ludwig, and Drew Weissman, "Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.", Nucleic Acids research, Oxford University Press, GB, GB , (20111101), vol. 39, no. 21, doi:10.1093/nar/gkr695, ISSN 1362-4962, pages e142 - e142-10, XP002696190
OPPOSITION- Weide Benjamin; Carralot Jean-Philippe; Reese Anne; Scheel Birgit; Eigentler Thomas Kurt; Hoerr Ingmar; Rammensee Hans-Georg; Garbe Claus; Pascolo Steve, "Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.", Journal of Immunotherapy, US , (20080201), vol. 31, no. 2, doi:10.1097/CJI.0b013e31815ce501, ISSN 1524-9557, pages 180 - 188, XP009125242
OPPOSITION- K. Muthumani, D. Falzarano, E. L. Reuschel, C. Tingey, S. Flingai, D. O. Villarreal, M. Wise, A. Patel, A. Izmirly, A. Aljuaid, A. M. Seliga, G. Soule, M. Morrow, K. A. Kraynyak, A. S. Khan, D. P. Scott, F. Feldmann, R. Lacasse, K. Meade-White, A. Okumura, K. E. Ugen, N. Y. Sardesai, J. J. Kim, G. Kobinger, H. Feldmann, D. B. Weiner, "A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates", SCIENCE TRANSLATIONAL MEDICINE, (20150819), vol. 7, no. 301, doi:10.1126/scitranslmed.aac7462, ISSN 1946-6234, pages 301ra132 - 301ra132, XP055271204
OPPOSITION- Li Chunhua, Li Wentao, Lucio De Esesarte Eduardo, Guo Hongbo, Van Den Elzen Paul, Aarts Eduard, Van Den Born Erwin, Rottier Peter J. M., Bosch Berend-Jan, "Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies", Journal of Virology, US , (20170615), vol. 91, no. 12, doi:10.1128/JVI.00273-17, ISSN 0022-538X, pages 1 - 16, XP093144044
OPPOSITION- S. Van Boheemen, M. De Graaf, C. Lauber, T. M. Bestebroer, V. S. Raj, A. M. Zaki, A. D. M. E. Osterhaus, B. L. Haagmans, A. E. Gorbalenya, E. J. Snijder, R. A. M. Fouchier, "Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans", mBio, (20121120), vol. 3, no. 6, doi:10.1128/mBio.00473-12, ISSN 2150-7511, pages 1 - 9, XP055128733
OPPOSITION- Schuurhuis Danita H., Fu Nathalie, Ossendorp Ferry, Melief Cornelis J.M, "Ins and Outs of Dendritic Cells", International Archives of Allergy and immunologyy, CH , (20060101), vol. 140, no. 1, doi:10.1159/000092002, ISSN 1018-2438, pages 53 - 72, XP093144014
OPPOSITION- Pascolo S, "Messenger RNA-based vaccines", Expert opinion on biological therapy, (20040801), vol. 4, no. 8, doi:10.1517/14712598.4.8.1285, ISSN 1471-2598, pages 1285 - 1294, XP009095328
OPPOSITION- Deering Raquel P; Kommareddy Sushma; Ulmer Jeffrey B, "Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.", Expert opinion on drug delivery, Informa Healthcare, UK, UK , (20140601), vol. 11, no. 6, doi:10.1517/17425247.2014.901308, ISSN 1744-7593, pages 885 - 899, XP009183535
OPPOSITION- Deering Raquel P; Kommareddy Sushma; Ulmer Jeffrey B, "Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.", Expert opinion on drug delivery, UK , (20140601), vol. 11, no. 6, doi:10.1517/17425247.2014.901308, ISSN 1744-7593, pages 885 - 899, XP009183535
OPPOSITION- P. MIDOUX et al., "Lipid-based mRNA vaccine delivery systems", Expert Review of Vaccines, (20150000), vol. 14, no. 2, doi:10.1586/14760584.2015.986104, pages 221 - 234, XP055439935
OPPOSITION- Del Pozo-Rodriguez Ana, Delgado Diego, A. Solinis Maria, R. Gascon Alicia, "Lipid Nanoparticles as Vehicles for Macromolecules: Nucleic Acids and Peptides", Recent patents on drug delivery & formulation, NL , (20110901), vol. 5, no. 3, doi:10.2174/187221111797200515, ISSN 1872-2113, pages 214 - 226, XP093005538
OPPOSITION- Zhao Jing, Zhao Ye, Zhang Guozhong, "Key Aspects of Coronavirus Avian Infectious Bronchitis Virus", Pathogens, MDPI AG, (20230511), vol. 12, no. 5, doi:10.3390/pathogens12050698, ISSN 2076-0817, page 698, XP093137811
OPPOSITION- Yuen Tam, Chen Sam, Cullis Pieter, "Advances in Lipid Nanoparticles for siRNA Delivery", Pharmaceutics, (20130901), vol. 5, no. 3, doi:10.3390/pharmaceutics5030498, pages 498 - 507, XP055246895
OPPOSITION- Yen Cu, Kate Broderick, Kaustuv Banerjee, Julie Hickman, Gillis Otten, Susan Barnett, Gleb Kichaev, Niranjan Sardesai, Jeffrey Ulmer, Andrew Geall, "Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ", Vaccines, vol. 1, no. 3, doi:10.3390/vaccines1030367, pages 367 - 383, XP055130913
OPPOSITION- Verma Vineet, Maity Jyotirmoy, Maikhuri Vipin K, Sharma Ritika, Ganguly Himal K, Prasad Ashok K, "Double-headed nucleosides: Synthesis and applications", Beilstein Journal of Organic Chemistry, (20210608), vol. 17, doi:10.3762/bjoc.17.98, pages 1392 - 1439, XP093066454
OPPOSITION- A. REICHMUTH et al., "mRNA vaccine delivery using lipid nanoparticles", Therapeutic Delivery, (20160000), vol. 7, no. 5, doi:10.4155/tde-2016-0006, pages 319 - 334, XP055401839
OPPOSITION- Karl-Josef Kallen, Regina Heidenreich, Margit Schnee, Benjamin Petsch, Thomas Schlake, Andreas Thess, Patrick Baumhof, Birgit Scheel, Sven D Koch, Mariola Fotin-Mleczek, "A novel, disruptive vaccination technology: Self-adjuvanted RNActive® vaccines", Human vaccines & immunotherapeutics, (20131001), vol. 9, no. 10, doi:10.4161/hv.25181, ISSN 21645515, pages 2263 - 2276, XP055126357
OPPOSITION- Thomas Schlake, Andreas Thess, Mariola Fotin-Mleczek, Karl-Josef Kallen, "Developing mRNA-vaccine technologies", RNA BIOLOGY, (20121101), vol. 9, no. 11, doi:10.4161/rna.22269, ISSN 1547-6286, pages 1319 - 1330, XP055561756
SEARCH- FREDERIC MARTINON ET AL, "Induction of virus-specific cytotoxic T lymphoytes in vivo by liposome-entrapped mRNA", EUR. J. IMMUNOL, (19930101), vol. 23, pages 1719 - 1722, XP055337978 [Y] 1-16 * The whole document, in particular page 1720, left-hand column, first paragraph of the Results and Discussion section; page 1721, left-hand column, first 4 lines of the third paragraph *-
SEARCH- DU L ET AL, "Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines", VIROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 353, no. 1, doi:10.1016/J.VIROL.2006.03.049, ISSN 0042-6822, (20060915), pages 6 - 16, (20060915), XP024896372 [Y] 1-16 * Title; Results section *
SEARCH- SHIM BYOUNG-SHIK ET AL, "Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses", BMC IMMUNOLOGY, BIOMED CENTRAL, LONDON, GB, (20101231), vol. 11, no. 1, doi:10.1186/1471-2172-11-65, ISSN 1471-2172, page 65, XP021086526 [Y] 1-16 * Title; Results section *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents